Clinical Trial

Comparative Study of Blood Loss in Total Laparoscopic Hysterectomy by Ligation the Uterine Arteries in Different Techniques.

Completed
View on ClinicalTrials.gov →
Summary
Following Caesarean section, hysterectomy is the second most common major gynecological surgery, with approximately 600,000 procedures performed annually in the USA. Since Reich et al. first reported a total laparoscopic hysterectomy (TLH) in 1989, numerous studies have confirmed its feasibility and reproducibility. Evidence increasingly supports TLH over vaginal hysterectomy (VH) and total abdominal hysterectomy (TAH) for benign gynecological conditions. The development and rapid advancement of laparoscopic instruments and techniques have enabled the safe and successful completion of complex procedures using minimally invasive approaches. Women with a higher BMI or requiring complex surgeries benefit from reduced postoperative complications with laparoscopic operations.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-09; most recent amendment 2026-05-01.
Status change: Recruiting → Completed 2026-05-01
Status change: Not Yet Recruiting → Recruiting 2025-03-16
Trial Details
NCT Number NCT06875518
Lead Sponsor Mostafa Bahaa
Conditions Gynecologic Disease
Enrollment 60 participants
Start Date 2025-03-12
Primary Completion 2025-06-20 (estimated)
Study Completion 2025-06-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-04